SGS’s Robert Cartee, PhD Discusses Cell & Gene Therapy Innovations

[Article Title]

SGS is a leading global Testing, Inspection, and Certification (TIC) enterprise, and offers support to pharmaceutical and biotech firms in their Cell and Gene Therapies (CGT) development. SGS provides testing services for raw materials, drug substances, and drug products throughout all stages of product development in CGT manufacturing. Download this Q&A with Robert Cartee, PhD, Senior Director of Biopharmaceutical Services with SGS North America Inc., to learn more about the ways in which SGS is bringing innovation and value to its customers in the CGT field.

Download Document

    Please fill out the information below. If you are already registered, or have requested a quote before, and this information will be filled out for you.

  • Please enter the name of the company or institution you work at.

  • Please enter your mailing address.

  • Please enter the e-mail address you would like to be contacted at.

  • Please enter the phone number you would like to be contacted at.

  • By downloading this content, I agree that SGS can use my data for the purposes of dealing with my request, in accordance with the SGS Online Privacy Statement. SGS may also contact me with information on webinars, news, and events, and their experts can contact me about cell and gene therapy testing solutions.

  • By submitting this form, you consent to American Pharmaceutical Review storing your email address and contact information, transmitting your contact information to selected trusted partners, and customizing your experience based on the data you enter.